高级检索
当前位置: 首页 > 详情页

An Arg124Cys mutation in transforming growth factor β-induced gene associated with lattice corneal dystrophy type I in a Chinese pedigree

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Shanxi Canc Res Inst, Taiyuan, Peoples R China [2]Chinese Acad Med Sci CAMS & Peking Union Med Coll, Inst Basic Med Sci, Dept Biochem, Beijing 100005, Peoples R China [3]C Mer Dennis Lam Eye Hosp, Beijing, Peoples R China [4]Chinese Peoples Liberat Army Gen Hosp, Dept Ophthalmol, Beijing, Peoples R China [5]Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Inst Ophthalmol,Beijing Ophthalmol & Visu, Beijing, Peoples R China
出处:
ISSN:

关键词: LCD I mutation R124C TGFBI

摘要:
Purpose: To identify a clinical and genetic form of a large Chinese family with an autosomal-dominant lattice corneal dystrophy type I (LCD I). Methods: The patients' eyes were examined on the basis of slit-lamp microscopy, and other clinical records were also collected. Genomic DNA was extracted from peripheral leukocytes of the affected patients and their unaffected family members. Each previous reported mutation of the transforming growth factor beta-induced gene (TGFBI) gene was amplified by touch-down polymerase chain reaction and directly sequenced to verify the disease-causing mutation. Results: Typical clinical features of LCD I were found by slit-lamp photography in these affected Chinese pedigrees. A heterozygous single base-pair transition from C to T (c.418 C > T), leading to amino acid substitution Arg124Cys (R124C) in the encoded TGFBI protein, was detected in all of the eighteen affected patients. The same mutation was not found in unaffected family members. Conclusion: The R124C mutation hot spot, which was relatively rare in China, was responsible for LCD I in the large family. Molecular genetic analysis of TGFBI gene can offer an accurate diagnosis of patients with lattice corneal dystrophies in the clinical treatment.

基金:

基金编号: 82171101 BHTR-KFJJ-202001 201803D31166 201801D121303

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 4 区 医学
小类 | 4 区 眼科学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 眼科学
JCR分区:
出版当年[2020]版:
Q4 OPHTHALMOLOGY
最新[2023]版:
Q2 OPHTHALMOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者机构: [1]Shanxi Canc Res Inst, Taiyuan, Peoples R China
通讯作者:
通讯机构: [2]Chinese Acad Med Sci CAMS & Peking Union Med Coll, Inst Basic Med Sci, Dept Biochem, Beijing 100005, Peoples R China [5]Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Inst Ophthalmol,Beijing Ophthalmol & Visu, Beijing, Peoples R China [*1]Department of Biochemistry, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC), Beijing 100005, PR China [*2]Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University Beijing Ophthalmology & Visual Sciences Key Laboratory, Beijing 100730, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:23818 今日访问量:0 总访问量:1294 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)